FDA Orange Book · active-ingredient family
Thallous chloride tl-201
Thallous chloride tl-201 is approved as 4 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:THALLOUS CHLORIDE TL 201 · NDA 018110
4
Brand (NDA)
2
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| THALLOUS CHLORIDE TL 201RLD | GE HEALTHCARE | NDA 018110 | — | Feb 27, 1996 | |
| THALLOUS CHLORIDE TL 201RLD | CURIUM | NDA 018150 | — | Approved Prior to Jan 1, 1982 | |
| THALLOUS CHLORIDE TL 201RLD×2 | LANTHEUS MEDCL | NDA 017806 | — | Approved Prior to Jan 1, 1982 | |
| THALLOUS CHLORIDE TL 201 | BRACCO | NDA 018548 | — | Dec 30, 1982 |
Generic (ANDA) products (2)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| THALLOUS CHLORIDE TL 201 | CURIUM | ANDA 077698 | — | Nov 09, 2006 | |
| THALLOUS CHLORIDE TL 201 | TRACE LIFE | ANDA 075569 | — | Nov 21, 2001 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Thallous chloride tl-201 — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
